Position in SLGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,341,272
-$1,393,764 QoQ
Shares Held
274,363
0.0% QoQ
Ownership
8.39%
of shares outstanding
% of Portfolio
4.79%
of 13F equity value
Holder Rank
#2
of 24 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SLGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREAT POINT PARTNERS LLC holds $397,271,949 across 33 Biotechnology names. SLGL ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VOR |
Vor Biopharma Inc.
|
1,700,000 | $31,297,000 | |
| 2 | ABVX |
Abivax S.A.
|
204,314 | $27,226,883 | |
| 3 | VERA |
Vera Therapeutics, Inc.
|
600,836 | $25,781,872 | |
| 4 | ZURA |
Zura Bio Ltd
|
4,215,930 | $24,873,987 | |
| 5 | ALMS |
Alumis Inc.
|
856,061 | $24,089,556 | |
| 6 | SLGL |
Sol-Gel Technologies Ltd.
This page
|
274,363 | $20,341,272 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
425,000 | $19,992,000 | |
| 8 | ANNX |
Annexon, Inc.
|
3,500,000 | $19,985,000 |
All Filings in SLGL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,341,272 | 274,363 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,735,036 | 274,363 | Shares | Defined | 2026-05-15 | |
| 2026-03-24 | $21,951,783 | 274,363 | Shares | Sole | 2026-03-31 | |
| No filing history on record for this holder in this stock. | ||||||